Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-20-014223

EVP, CFO & CBO acquired 6,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mahatme Sandesh · EVP, CFO & CBO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-28 Grant or award : show line 1 in the form +6,700 36,879 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-02-28 Grant or award : show line 2 in the form Stock option (right to buy) +37,500 $114.47 2030-02-28 37,500 37,500 D
Loading xslF345X03/doc4.xml…